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Urgent carotid endarterectomy to prevent
recurrence and improve neurologic outcome in
mild-to-moderate acute neurologic events
Laura Capoccia, MD,a Enrico Sbarigia, MD,a Francesco Speziale, MD,a Danilo Toni, MD,b and
Paolo Fiorani, MD,a Rome, Italy
Objectives: This study evaluated the safety and benefit of urgent carotid endarterectomy (CEA) in patients with carotid
disease and an acute stable neurologic event.
Methods: The study involved patients with acute neurologic impairment, defined as >4 points on the National Institutes
of Health Stroke Scale (NIHSS) evaluation related to a carotid stenosis>50% who underwent urgent CEA. Preoperative
workup included neurologic assessment with the NIHSS on admission or immediately before surgery and at discharge,
carotid duplex scanning, transcranial Doppler ultrasound imaging, and head computed tomography or magnetic
resonance imaging. End points were perioperative (30-day) neurologic mortality, significant NIHSS score improvement
or worsening (defined as a variation >4), and hemorrhagic or ischemic neurologic recurrence. Patients were evaluated
according to their NIHSS score on admission (4-7 or >8), clinical and demographic characteristics, timing of surgery
(before or after 6 hours), and presence of brain infarction on neuroimaging.
Results: Between January 2005 and December 2009, 62 CEAs were performed at a mean of 34.2  50.2 hours (range,
2-280 hours) after the onset of symptoms. No neurologic mortality nor significant NIHSS score worsening was detected.
The NIHSS score decreased in all but four patients, with no new ischemic lesions detected. The mean NIHSS score was
7.05  3.41 on admission and 3.11  3.62 at discharge in the entire group (P < .01). Patients with an NIHSS score of
>8 on admission had a bigger score reduction than those with a lower NIHSS score (NIHSS 4-7; mean 4.95  1.03
preoperatively vs 1.31  1.7 postoperatively, NIHSS >8 10.32  1.94 vs 4.03  3.67; P < .001).
Conclusions: In patients with acute neurologic event, a high NIHSS score does not contraindicate early surgery. To date,
guidelines recommend treatment of symptomatic carotid stenosis <2 weeks from onset of symptoms to minimize the
neurologic recurrence. Our results suggest that minimizing the time for intervention not only reduces the risk of
recurrence but can also improve neurologic outcome. (J Vasc Surg 2011;53:622-8.)
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eThe efficacy of carotid endarterectomy (CEA) in pre-
venting stroke has been demonstrated in well-known large
randomized prospective trials.1,2 Subgroup analysis of
those studies has defined some guidelines to treat recently
neurologic symptomatic patients who have been moni-
tored for many years. According to those studies, surgery
had to be delayed for at least 6 weeks from the neurologic
event because of the risk of hemorrhagic transformation of
the acute brain ischemic lesion. Nevertheless, recent studies
have emphasized the safety of early CEA in patients with
nondisabling stroke or acute neurologic events.3-7 More-
over, previous reports on early CEA8,9 have shown that
expedited carotid revascularization can improve neurologic
outcome, as evaluated by the National Institutes of Health
Stroke Scale (NIHSS), probably recruiting brain areas that
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622an be reperfused before cell death occurs. The aim of this
rospective study was to evaluate the safety and benefit of
rgent CEA in a consecutive series of patients presenting
ith carotid disease and a mild or moderate acute stable
eurologic event.
ETHODS
The intervention protocol reported in this article was
pproved by the Local Ethical Committee. All patients gave
heir written informed consent before CEA.
Patient population. From January 2005 to Decem-
er 2009, all patients presenting to our Academic Emer-
ency Department with neurologic symptoms were evalu-
ted by a neurologist who established the initial neurologic
everity and an NIHSS score. Onset time was recorded in
ll patients. When the onset of neurologic symptoms was
nknown, it was considered as the last time the patient was
een free from symptoms.
All patients underwent a complete medical examina-
ion, NIHSS assessment, blood test, electrocardiogram,
nd cerebral computed tomography (CT) or magnetic
esonance imaging (MRI) to assess the presence, nature,
nd extension of brain lesions. Carotid duplex ultrasound
maging and transcranial Doppler (TCD) imaging were
erformed in all patients to detect the eventual source of
mbolism. All patients received body-weight-adapted low-
olecular-weight heparin (100 IU/kg twice daily), to-
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Volume 53, Number 3 Capoccia et al 623gether with their scheduled antihypertensive, statin, or
antidiabetic medications. Blood pressure, temperature, and
serum levels of glucose were strictly monitored.
In 113 of 1889 patients (6%) admitted to our Emer-
gency Department Stroke Unit, an ipsilateral50% carotid
stenosis (North American Symptomatic Carotid Endarter-
ectomy Trial evaluation criteria2) was encountered, and 62
(55%) were scheduled for urgent CEA, respecting inclusion
and exclusion criteria and stabilization of symptoms at time
of CEA (Table I).
The study excluded patients who received thrombo-
lytic treatment with recombinant tissue plasminogen acti-
vator (rt-PA) and CEA (European Medicines Evaluation
Agency Criteria, Safe Implementation of Thrombolysis in
Stroke-Monitoring Study10). Patients who presented with
unstable symptoms and underwent urgent CEA were ex-
cluded from the present analysis.
Perioperative management. CEA was performed un-
der general anesthesia in all cases. Routine physiologic
monitoring included pulse oximetry, electrocardiogram,
and invasive blood pressure measurement using the radial
artery. Before the internal carotid artery (ICA) was
clamped, heparin (5000  2000 IU, depending on body
weight) was injected intravenously. Neurologic status as-
sessment was performed using near-infrared spectroscopy
(NIRS) in all cases and TCD imaging whenever possible
throughout the entire procedure.
CEA was performed by standard surgical protocol in all
Table I. Inclusion and exclusion criteria for patient
enrollment
Inclusion criteria
Clear time of onset of symptoms
NIHSS score 22
Recent ischemic hemispheric brain infarct 33% of the middle
cerebral artery area regardless of BBB disruption at CT or
MRI scans
Internal carotid artery stenosis 70% or 50% with an
ulcerated surface plaque at US evaluation
Patent middle cerebral artery in the detectable portion M1 and
M2
Exclusion criteria
According to clinical presentation on admission
No clear time of onset of symptoms
Severe neurologic deficit (NHISS score 22)
Cerebral ischemia onset with seizures
Previous ischemic or hemorrhagic stroke with residual
severe deficit (Modified Rankin Scale 2)
History of cerebral hematomas
Any other cerebral disease with residual permanent deficit
According to CT or MRI scans on admission
Recent ischemic hemispheric brain infarct 33% of the
middle cerebral artery area
Presence of cerebral hemorrhage
Brain tumor
Cerebral arteriovenous malformation
Cerebral aneurysm
BBB, Blood brain barrier; CT, computed tomography; MRI, magnetic
resonance imaging; NIHSS, National Institutes of Health Stroke Scale; US,
ultrasound.cases. Dacron patch angioplasty was performed in 43 pa- bients (69.4%) using 5-0 polypropylene suture in a semi-
ontinuous fashion, and direct closure was made in 19
30.6%) in a continuous fashion. A shunt was used in 13
atients (21%) when a 50% reduction in the middle
erebral artery mean velocity at TCD monitoring or a
20% reduction of regional oxygen saturation at NIRS
onitoring was detected.
In the postoperative period, patients were maintained
nder a low dosage of heparin (4000 IU enoxaparin so-
ium) together with their scheduled medications. Systolic
lood pressure was maintained140 mmHg in the imme-
iate postoperative period. Antiplatelet therapy with acetyl-
alicylic acid (100 mg daily) was started at discharge.
All patients were evaluated by an experienced neurolo-
ist (D.T.) immediately after surgery, at discharge, and at
he 1-month follow-up with recording of any neurologic
dverse event and an NIHSS score assessment. Postopera-
ive neuroimaging was only performed in those patients
resenting a worsening NIHSS score.
End points and statistical analysis. Patients were
valuated according to neurologic impairment assessed by
he NIHSS score on admission or immediately before
urgery (score 4-7, mild acute neurologic impairment;
core 8, moderate acute neurologic impairment11), clin-
cal and demographic characteristics (Tables II and III),
iming of surgery (before or after 6 hours), and presence of
able II. Analysis of clinical and demographic
haracteristics with respect to significant (4)
ostoperative National Institutes of Health Stroke Scale
NIHSS) score decreasea
NIHSS score
decrease 4
ariable No. (%) No. (%) P
atients, No. 62 28
ge 70 years 22 (35.5) 12 (54.5) .11
ge 70 years 40 (64.5) 16 (40)
ale 51 (82.2) 24 (47) .22
ypertension 49 (79) 23 (46.9) .21
iabetes 21 (33.8) 9 (42.8) .50
yperlipemia 19 (30.6) 9 (47.3) .51
moke 37 (59.6) 20 (54) .05
oronary artery
diseaseb
20 (32.2) 10 (50) .18
rain infarction on
admission
36 (58) 16 (44.4) .20
EA 6 hours 22 (35.4) 10 (45.4) .60
IHSS score
4-7 on admission 40 (64.5) 11 (27.5) .0001
8 22 (35.5) 17 (77.2)
CA stenosis
50%-69% 22 (35.5) 11 (50) .16
70% 40 (64.5) 16 (40)
laque composition
Hyperechoic 15 (24.2) 7 (46.6) .56
Hypoanechoic 47 (75.8) 21 (44.7)
EA, Carotid endarterectomy; ICA, internal carotid artery.
Categoric data analysis by Fisher’s exact test.
Includes myocardial infarction, angina, congestive heart failure, valvular
eart disease.rain infraction on neuroimaging.
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March 2011624 Capoccia et alPrimary perioperative (30-day) outcome measures
were neurologic mortality; significant NIHSS score im-
provement or worsening, defined as a variation 4 at
postoperative day 30; and hemorrhagic or ischemic neuro-
logic recurrence.12 Neurologic recurrence was defined as a
new ischemic event or a significant worsening of the previ-
ous NIHSS score 4 lasting 24 hours.12
Patients were divided for analysis into subgroups ac-
cording to perioperative characteristics and were compared
with respect to the occurrence of postoperative neurologic
events or significant NIHSS score variation (4). Univari-
ate analysis was performed by t-test for continuous vari-
ables, and results are expressed as mean  standard devia-
tion (SD), and the 2 and Fisher’s exact (one-sided) tests
were used for categoric values and are expressed as numbers
and percentages. A value of P  .05 was considered statis-
tically significant.
RESULTS
Mean age of the entire population was 68  10 years
(range, 51-90 years), and 51 (82.2%) were men. Hyperten-
sion was discovered in 49 patients (79%), diabetes in 21
(33.8%), hyperlipemia in 19 (30.6%), coronary artery dis-
ease in 20 (32.2%), and smoking history in 37 (59.6%).
Stenosis percentage ranged from 50% to 69% in 22 patients
(35.5%) and was70% in 40 (64.5%). Plaque composition
was hypoanechoic in 47 patients (75.8%) and hyperechoic
Table III. Analysis of clinical and demographic
characteristics with respect to postoperative National
Institutes of Health Stroke Scale (NIHSS) score variationa
Variable
NIHSS score
decrease
95% CI t-test PMean  SD
Age 70 years 4.81  3.19 5.82-3.79 0.53 .60
Age 70 years 4.47  2.63 5.23-3.71
Male 4.65  2.99 5.32-3.98 0.39 .70
Hypertension 4.66  2.82 5.35-3.97 0.43 .66
Diabetes 4.38  3.10 5.43-3.33 0.49 .62
Hyperlipemia 3.81  3.16 4.90-2.71 1.71 .09
Smoke 5.18  3.10 5.94-4.41 2.37 .02
Coronary artery
diseaseb
4.64  2.97 5.71-3.57 0.11 .91
Brain infarction on
admission
4.26  3.22 5.05-3.47 1.29 .20
CEA 6 hours 4.39  3.35 5.40-3.37 0.50 .62
NIHSS score
4-7 on admission 3.64  1.83 4.32-2.95 4.66 .0001
8 6.29  3.47 7.20-5.38
ICA stenosis
50%-69% 4.33  3.37 5.31-3.35 0.66 .51
Stenosis 70% 4.75  2.46 5.53-3.97
Plaque composition
Hyperechoic 4.38  3.10 5.43-3.33 0.49 .62
Hypoanechoic 4.70  2.71 5.45-3.95
CEA, Carotid endarterectomy; CI, confidence interval; ICA, internal ca-
rotid artery.
aContinuous values analysis by t-test.
bMyocardial infarction, angina, congestive heart failure, valvular heart dis-
ease.in 15 (24.2%) at the preoperative ultrasound evaluation. oAt admission, 40 patients (64.5%) presented a mean
IHSS score of 4.95  1.03 (range, 4-7; mild neurologic
mpairment), and 22 (35.5%) had a score of 10.32  1.94
8 is moderate neurologic impairment). Among those, 5
atients presented a score of 8, 16 had a score between 9
nd 14, and 1 patient presented a score of 15.
The first CT or MRI scans showed an acute brain
nfarction in 36 patients (58%). The brain infarctions were
mean diameter of 1.2 cm (range, 0-2.1 cm). The overall
ean time from neurologic event to surgery was 34.2 
0.2 hours (median, 31.4 hours). CEA was performed in
2 patients (35.4%)6 hours from neurologic event and in
0 (64.5%)6 hours. Among them, 12 underwent surgery
48 hours from onset of symptoms. The mean length of
ostoperative in-hospital stay was 3.3  1.26 days in the
ntire group.
Perioperative (30-day) neurologic outcomes. No
eurologic mortality, hemorrhagic brain infarction, or sig-
ificant ischemic recurrence (NIHSS worsening4 points)
as recorded. One patient (1.6%) died of myocardial in-
arction on postoperative day 2.
The mean NIHSS score was 7.05 3.41 on admission
nd 3.11 3.62 at discharge in the entire group (P .01).
his NIHSS score decrease was observed in all but four
atients (93.5%). A score increase of 3 points was detected
ostoperatively in one patient whose preoperative score was
and of 2 points in two patients whose preoperative scores
ere 5 and 6. In one patient, the preoperative score of 6
emained stable after surgery and at the 30-day follow-up.
n all of them, preoperative CT scans had shown ipsilateral
schemic lesions with perilesional edema. No new ischemic
esion was detected at postoperative CT or MRI scans, so
he clinical worsening was attributed to edema enlarge-
ent. The neurologic worsening occurred in all patients in
heir ipsilateral motor function.
The strongest decrease in NIHSS score after CEA
ccurred in patients presenting with 8 score on admis-
ion, varying from 10.32  1.94 to 4.03  3.67. The
ifference in the mean score decrease was statistically sig-
ificant when compared with that occurring in the patients
hose scores were 4 to 7, whosemean score decreased from
.95 1.03 to 1.31 1.7 (P .0001, Tables II and III).
An NIHSS score decrease of4 points was detected in
8 patients (45.1%). The significant score decrease was
etected in 11 patients with mild neurologic impairment
27.5% of patients presenting with NIHSS score between 4
nd 7) and in 17 with moderate neurologic impairment
77.2% of patients presenting with NIHSS score 8; P 
0001).
Clinical and demographic characteristics (age, sex, hy-
ertension, diabetes, hyperlipemia, smoke, coronary artery
isease, internal carotid artery stenosis percentage, plaque
omposition) presented no significant relationship when
nalyzed with respect to their effect on NIHSS score de-
rease both in continuous and categoric data analysis (Figs
and 2, Tables II and III).
Analysis of the NIHSS score with respect to time fromnset of symptoms to intervention showed no differences
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Volume 53, Number 3 Capoccia et al 625in the group operated on6 hours compared with patients
who underwent CEA 6 hours from the onset of symp-
toms (10 and 18 patients, respectively, P  .60).
Analysis of the NIHSS score with respect to the pres-
ence of brain infarction on admission showed no statisti-
cally significant differences, given a significant (4) NIHSS
score decrease in 16 patients (44.4%) with brain infarction
on admission and 12 patients (46.1%) with no brain infarc-
tion (P  .20). Results of the analysis are summarized in
Figs 1 and 2 and in Tables II and III.
DISCUSSION
Nowadays, CEA is considered a safe and effective inter-
vention to prevent ischemic stroke in patients with moder-
ate or severe symptomatic carotid artery stenosis.13,14 In
experienced centers, neurologic mortality and morbidity
rates after CEA of up to 8.4% are usually reported in
recently symptomatic patients with severe carotid steno-
sis.15,16 In the present series, we detected no neurologic
Fig 1. The postoperative National Institutes of Health Stroke
Scale score decrease in stroke patients was analyzed with respect to
clinical and demographic characteristics. Continuous values ex-
pressed as mean and standard deviation (SD).
Fig 2. The postoperative National Institutes of Health Stroke
Scale score decrease in stroke patients was analyzed with respect to
clinical and demographic characteristics. Continuous values are
expressed as the mean and standard deviation (SD).mortality in a subset of patients at high risk of intraoperative stroke event because of the short interval between the
eurologic event and surgery and a strict treatment proto-
ol.
Risk of recurrence. It is a common opinion that
ntraoperative stroke risk is very high in very recently symp-
omatic patients.16 Recent studies have shown symptom-
tic plaques characteristically show features on ultrasound
maging and histology that justify their instability and their
endency to embolize.17-19 Such unstable features are re-
ponsible for the high risk of recurrence in symptomatic
atients more than previously considered. The old assump-
ion that the early risk of stroke after a transient ischemic
ttack (TIA) or minor stroke was only about 1% to 2% at 7
ays and 2% to 4% at 30 days was derived from a collection
f cohort studies biased in design.20-23 Those studies were
nclined to recruit patients some time after the neurologic
vent, excluding those who sustained a stroke in the inter-
ening period. Conversely, a meta-analysis of recent stud-
es24 published in 2007 observed that the risk of stroke was
.7% at 2 days and 10.4% at 7 days, thus reporting much
igher values than previously accepted.
In a review of data on 2416 patients who had presented
ith an ischemic stroke, Rothwell et al25 observed that
pproximately one-quarter of patients reported a preceding
IA, with 17% of those occurring at the same day of stroke,
% happening on the day before the stroke, and 43% of
verall TIAs occurring7 days before stroke onset. Lovett,
t al23 reported that stroke due to “large artery” disease (ie,
redominantly involving the carotid artery) was associated
ith the highest rate of early recurrent stroke (4% at 7 days,
2.6% at 30 days, 19.2% at 3 months). In a recent observa-
ional study, Ois et al26 recorded a neurologic recurrence of
0.9% within 72 hours, 6.7% between 72 hours and 7 days,
nd 3.7% at 14 days in 163 patients with symptomatic
arotid stenosis and initial mild stroke or TIA.
In this context, the National Institute for Clinical Ex-
ellence recommendation that all patients should be treated
2 weeks of onset of symptoms27 has been superseded by
he United Kingdom Department of Health recommenda-
ion that carotid intervention should be regarded as an
mergency procedure in stable symptomatic patients and
hould ideally be performed 48 hours of a TIA or minor
troke.28 In the present series, the mean time from the
ndex event and surgery was 34.2 50.2 hours, with about
ne-third of patients operated on 6 hours of symptoms
nset, thus partially justifying the absence of recurrences
eported or detected by postoperative CT or MRI scans.
Risk of hemorrhagic transformation of brain in-
arct. If any intervention delay rapidly diminishes the
enefit accruing to the patient in stroke prevention,16
evertheless, the risk of hemorrhagic transformation of the
schemic area is a cause of major concern. Bond et al29
ystematically reviewed the 30-day risk of stroke/death in
278 patients presenting with a minor stroke who under-
ent early CEA (3 to 6 weeks) vs late CEA (3 to 6
eeks) and demonstrated that no excess risk was associated
ith early vs late CEA, provided the patient presented with
table neurologic symptoms.
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March 2011626 Capoccia et alA literature review of 30-day outcomes and conversion
rates to intracranial hemorrhage in eight studies published
from 2000 to 2007, where the median delay from onset of
events to surgery was 14 days,16 concluded that the
overall 30-day death/stroke rates probably were higher
than those cited in the “popular” literature, whereas the
16.4% risk was probably not typical of the type of patient
normally being considered for early intervention. The rate
of conversion to intracranial hemorrhage was reassuringly
low, ranging from 0% to 4%, with the highest value encoun-
tered in a series of patients with positive CT scans not
associated with symptoms.
Following previous reports by our group8,9 and accord-
ing to the literature review,16 a strict selection protocol
could help identify those patients who could most benefit
from very early CEA and, above all, who should avoid early
surgery, given the high risk of recurrence and hemorrhagic
transformation. In the present series, the application of
those inclusion and exclusion criteria (see Table I) allowed
us to avoid any significant worsening of neurologic status.
In those patients not presenting an NIHSS score decrease,
no new ischemic lesion was detected at postoperative CT or
MRI scans, so that the worsening was attributed to perile-
sional brain edema. Conversely, an improved NIHSS score
was detected after surgery in 93.5% of patients, with the
highest decrease recorded in those patients presenting with
moderate neurologic impairment.
Brain tissue rescue. Apart from preventing ongoing
embolism or carotid thrombosis, the early CEA could
improve overall cerebral perfusion, restoring blood flow to
the ischemic penumbra and thus reducing neuronal loss.
Blood flow in the ischemic penumbra is far from normal,
but at the same time is not absent, so the hypoperfused
tissue can be still considered at risk for infarction but not
openly ischemic. In diffusion-weighted MRI, that area is
detected as a “mismatch” between perfusion and diffusion
scans.30,31 Expeditious blood flow restoration to that area,
which is exponentially larger depending on the diameter of
the ischemic area, could help in preventing progressive flow
reduction caused by perilesional edema. The same principle
governs thrombolytic therapy in acute cerebral arteries
occlusion, where rt-PA could be used 3 hours from the
event, with recovery of hypoperfused brain areas and clini-
cal status improvement.10
The main limitation of the present study is the small
number of patients. We report a single-center experience
with very early CEA in symptomatic patients. Although
they cannot be representative of the entire population,
nevertheless, the results follow those reported in a multi-
center experience gained in Italy8,9 that shared the same
treatment protocol.
In most cases, the short interval between observation
and surgery has not allowed us to properly classify patients
presenting with a stroke or a TIA. Nevertheless all patients
in the present series presented a neurologic impairment
(NIHSS score 4) at time of CEA.
When analyzing results, we divided patients with re-
spect to6 hours or6 hours from onset of symptoms tontervention. This time was chosen assuming that the flow
n the ischemic penumbra was close to zero. The survival
ime of neuronal cells and the consequent ability to recover
n case of ischemia are very short. In an emergency situa-
ion, it is quite impossible to know exactly the blood flow in
he ischemic penumbra, so the shortening of time from
eurologic event and intervention is mandatory.
ONCLUSIONS
Early CEA has proven to be effective in preventing
eurologic recurrence in symptomatic patients and is able
o guarantee a low risk of hemorrhagic conversion applying
proper treatment protocol. If the previous aim of urgent
EA is to prevent neurologic recurrence, the new and
hallenging goal is to rescue substantial brain tissue as soon
s possible. Close collaboration among neurologists, neu-
oradiologists, and vascular surgeons is mandatory to select
atients who could most benefit from urgent carotid revas-
ularization.
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Dr Ali AbuRahma (Charleston, WV). There is no doubt that
we tend to do procedures much earlier now than we did 20 to 30
years ago, but since the patients in your study were nonrandom-
ized, how do you know that the change didn’t just occur on its
own?
Dr Laura Capoccia. Thank you for your question. Of course,
I can’t derive evidence from such a small number of patients, and
sure enough, when looking at neurologic improvement, I have to
consider not only the procedure itself but, for example, heparin
administration or blood pressure control during the procedure. I
can’t be 100% sure that we don’t have other factors affecting our
results. I am just reporting what our results are. And those are that
the major part of our patients are improving neurologic outcome.
Of course, this is not direct evidence, this is indirect evidence;
nevertheless, it seems to relate to the brain tissue rescue.
Dr John Ricotta (Washington, DC). Could you tell us a little
bit more about medical efforts at plaque stabilization, antiplatelet,
heparin, statin use in your patients, and use of a shunt during
surgery. Do you routinely shunt these patients during surgery? Can
you comment on the alternative strategy of trying to stabilize these
patients for 3 or 4 days on medical therapy rather than moving
immediately to surgery?
Dr Capoccia. Regarding the second comment or question,
our treatment protocol is to operate on stable patients as soon as
possible, provided that the inclusion criteria are met. We think this
is the best strategy in order to minimize the recurrence risk and to
save the brain tissue. By the way, in this group of patients, allAnd to answer the first question, we don’t use routinely a
hunt. We generally use transcranial Doppler (TCD) monitoring
f patients, or if not possible, we have the near-infrared spectros-
opy (NIRS) monitoring. When we have evidence that the blood
ow to the brain is not enough, we use a shunt. In this group, 13
atients were submitted to carotid endarterectomy by use of a
hunt. Regarding therapy, all patients received their scheduled
ntihypertensive, antiplatelet, and statin therapy in the postopera-
ive period together with 4000 to 6000 IU of low-molecular-
eight-heparin.
Dr Ahmed Taha (Cairo, Egypt). How could you explain the
% incidence of reperfusion injury and hemorrhagic infarction in
our series? Is there any special protocol you followed in order to
ullify these complications, especially when the time between the
troke and surgery is that short?
Dr Capoccia. I am aware those were excellent results. I think
he main point of our study is the accuracy of the protocol with
espect to inclusion and exclusion criteria. This protocol allowed us
o include only patients who could really benefit from urgent
arotid endarterectomy CEA, thus excluding those at risk of hav-
ng a worsening of neurological status.
Dr R. Clement Darling (Albany, NY). We have done 300
EAs in acute stroke, and we have actually changed some of our
pproaches. We do it with eversion endarterectomy. We tend to
hunt these more aggressively, and we tend to do them under
eneral anesthesia, when we do 99% of our electives under
ervical block. How do you monitor their cerebral activity
uring your operation? And do you do them under general or
nder block?
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those patients. Our cerebral activity monitoring was by transcranial
Doppler whenever possible, and NIRS monitoring in all patients.
Dr Richard Cambria (Boston, Mass). This is a clinical decision-
making issue that is a common problem for vascular surgeons. You
reported on 62 patients that you treated, and I think most of us
would agree that many of the patients that you excluded are
patients that we would not operate on urgently. Can you tell us the
content of the whole series, in other words, how many exclusions
did you have in your cohort?
Dr Capoccia. I don’t remember the exact number, but the
whole cohort was around 110. They were all patients admitted
with a neurologic event and an ipsilateral carotid stenosis of50%.
So I can say about half of the patients admitted with a carotid-
related stroke could be submitted to urgent CEA.
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risk of stroke after TIA was 2%. However, contemporary studies
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5Dr Wilhelm Sandmann (Düsseldorf, Germany). Thank you
or your paper. It shows the persistence of Paolo Fiorani, who
lways stated that urgent endarterectomy is possible. But can you
ell us howmany occlusions you have found at the time of surgery?
ecause sometimes if it is an urgent case, you go ahead maybe also
ithout imaging, and when you open the carotid artery up it is
lready occluded. Did this happen in your series also?
Dr Capoccia. We treated patients with recently occluded
arotid artery, but they were not analyzed in this series. We
xcluded from this analysis patients presenting with thrombus in
he carotid artery or occlusion, because, of course, they were
nstable patients in our experience. Indeed, they were all patients
ith a patent carotid artery on admission and an occluded one in
he operating room, so all of them presented unstable or fluctuat-
ng symptoms and were excluded from the present analysis.INVITED COMMENTARYA. Ross Naylor, MD, FRCS, Leicester, United Kingd
This article will polarize opinion, depending on whether one
believes that symptomatic patients should be treated as emergen-
cies. Consequently, and notwithstanding the excellent results by
Capoccia et al, some surgeons will remain concerned that the small
numbers (12 patients per annum) mean that this series is too
selective to permit meaningful interpretation, given that others
have reported significant increases in procedural risks where ca-
rotid endarterectomy (CEA) was performed more urgently.1 In
the currently litigious era, is it any wonder that some surgeons
might encourage delays to minimize the procedural risk? By con-
trast, those aware of the very high natural history risk of stroke in
the first 72 hours after a transient ischemic attack (TIA) or minor
stroke will be pleased that evidence is now emerging that CEA can
be performed with relatively low risks in selected patients within
the hyperacute period.
So how should these data be interpreted? Tome, the first issue
is the definition of procedural stroke. I remain uncertain why
stroke was defined as being a deterioration of 4 points on the
National Institutes of Health Stroke Scale (NIHSS) score. In the
study by Capoccia et al, three patients increased their postoperative
NIHSS score by 2 or 3. In many units, these would be classified as
minor strokes leading to a death/stroke rate of 6.5% as opposed to
the 1.6% cited. But is a 6.5% risk too high? To this observer, the
answer is “no,” and this is crucial to changing attitudes about
whether early intervention increases the procedural risk to the
extent that it might negate any long-term benefit. Paradoxically,
meta-analyses suggest that the surgeon who operates early with a
10% risk may still prevent more strokes than the surgeon who waits
4 weeks and then operates with a 0% risk.2
The second issue is to explain the drive toward emergencyuggest that this value may be nearer 10%,3 while others have
eported that almost half of all strokes occurring 7 days do so
ithin the first 24 hours.4 Of concern to the vascular surgeon
hould be a recent Canadian study which showed that TIA patients
ith a 50% to 99% stenosis faced a 17% risk of recurrent stroke at 72
ours, 22% at 7 days, and 25% at 14 days.5 Those who retort that
hey never see such a high a rate of recurrent stroke on their CEA
aiting lists should be aware that most of these strokes will have
ccurred long before they ever had a chance to see the patient in
he first place!
For too long, TIA has been the poor relation of heart disease,
nd the time has now come for it to be treated on par with acute
yocardial infarction. However, this will require guideline makers
o recognize that surgeons who delay interventions so they can
ffer the lowest procedural risk may look good in league tables
ithout conferring much benefit to their patients!
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